The use of recombinant human erythropoietin stimulating factor in plastic surgery.
Aesthetic Plast Surg
; 28(3): 174-6, 2004.
Article
en En
| MEDLINE
| ID: mdl-15383887
Erythropoietin is the most important factor in the regulation of erythropoiesis. This study aimed to evaluate the efficacy of rhuESF for patients undergoing plastic surgical procedures during which notable blood loss is expected (reduction mammoplasty in cases of macromastia and abdominoplasty obese patients) to improve the full blood count and reduce the need for transfusion. The levels of hemoglobin were significantly greater for patients pretreated with erythropoietin and iron than for the control group.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Pérdida de Sangre Quirúrgica
/
Eritropoyetina
/
Mamoplastia
/
Hierro
/
Obesidad
Tipo de estudio:
Clinical_trials
Límite:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Aesthetic Plast Surg
Año:
2004
Tipo del documento:
Article
País de afiliación:
Italia
Pais de publicación:
Estados Unidos